The Advantage of Intermittent Hgh Therapy in Patients with Isolated and Combined Hgh Deficiency


Out of 46 patients treated by an intermittent HGH regime, 5 pts. with isol. HGH deficiency (IGHD) and 5 pts. with panhypopituitarism (CGHD) are presented. HGH was administered thrice weekly, 1–3 mg/injection, in courses of 3–14 months duration interspaced by intervals of 2–15 months. The patients received from 3–6 courses over a period of 2 3/12–6 3/12… (More)
DOI: 10.1203/00006450-197508000-00136


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.